title: [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
authors.forename: S
authors.initials: S
authors.lastname: Suzuki
authors.forename: H
authors.initials: H
authors.lastname: Akama
authors.forename: K
authors.initials: K
authors.lastname: Kume
authors.forename: E
authors.initials: E
authors.lastname: Higuchi
authors.forename: S
authors.initials: S
authors.lastname: Kamiyama
authors.forename: J
authors.initials: J
authors.lastname: Suzuki
authors.forename: N
authors.initials: N
authors.lastname: Ohara
authors.forename: E
authors.initials: E
authors.lastname: Yugeta
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: H
authors.initials: H
authors.lastname: Suzuki
mesh_terms: D000179:Acrylates / Q000627:therapeutic use*; D000818:Animals; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000188:drug therapy*; D011507:Proteinuria / Q000188:drug therapy*; D011692:Puromycin Aminonucleoside; D051381:Rats; D011919:Rats, Inbred Strains; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
chemical_list: D000179:Acrylates; D008689:Methacrylates; D011692:Puromycin Aminonucleoside; D013930:Thromboxane-A Synthase; C034364:ozagrel